FI91529B - Menetelmä uusien terapeuttisesti käyttökelpoisten pyrido/1,2,3-de//1,4/bentsoksatsiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten pyrido/1,2,3-de//1,4/bentsoksatsiinijohdannaisten valmistamiseksi

Info

Publication number
FI91529B
FI91529B FI891910A FI891910A FI91529B FI 91529 B FI91529 B FI 91529B FI 891910 A FI891910 A FI 891910A FI 891910 A FI891910 A FI 891910A FI 91529 B FI91529 B FI 91529B
Authority
FI
Finland
Prior art keywords
pyrido
preparation
therapeutically useful
benzoxazine derivatives
new therapeutically
Prior art date
Application number
FI891910A
Other languages
English (en)
Swedish (sv)
Other versions
FI891910A (fi
FI891910A0 (fi
FI91529C (fi
Inventor
Hirokazu Narita
Yozo Todo
Jun Nitta
Hiroyasu Takagi
Fumihiko Iino
Mikako Miyajima
Yoshikazu Fukuoka
Isamu Saikawa
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of FI891910A0 publication Critical patent/FI891910A0/fi
Publication of FI891910A publication Critical patent/FI891910A/fi
Publication of FI91529B publication Critical patent/FI91529B/fi
Application granted granted Critical
Publication of FI91529C publication Critical patent/FI91529C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06Peri-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
FI891910A 1988-04-23 1989-04-21 Menetelmä uusien terapeuttisesti käyttökelpoisten pyrido/1,2,3-de//1,4/bentsoksatsiinijohdannaisten valmistamiseksi FI91529C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP10062888 1988-04-23
JP10062888 1988-04-23
JP7587389 1989-03-28
JP1075873A JPH0228178A (ja) 1988-04-23 1989-03-28 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法

Publications (4)

Publication Number Publication Date
FI891910A0 FI891910A0 (fi) 1989-04-21
FI891910A FI891910A (fi) 1989-10-24
FI91529B true FI91529B (fi) 1994-03-31
FI91529C FI91529C (fi) 1994-07-11

Family

ID=26417038

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891910A FI91529C (fi) 1988-04-23 1989-04-21 Menetelmä uusien terapeuttisesti käyttökelpoisten pyrido/1,2,3-de//1,4/bentsoksatsiinijohdannaisten valmistamiseksi

Country Status (21)

Country Link
US (1) US4990508A (fi)
JP (1) JPH0228178A (fi)
KR (1) KR910005833B1 (fi)
AT (1) AT398422B (fi)
AU (1) AU601324B2 (fi)
BE (1) BE1003252A4 (fi)
CA (1) CA1340493C (fi)
CH (1) CH680793A5 (fi)
DE (1) DE3913245C2 (fi)
DK (1) DK175649B1 (fi)
ES (1) ES2016012A6 (fi)
FI (1) FI91529C (fi)
FR (1) FR2630441B1 (fi)
GB (1) GB2217710B (fi)
HU (2) HU205759B (fi)
IL (1) IL89931A (fi)
IT (1) IT1231760B (fi)
NL (1) NL192832C (fi)
NO (1) NO171214C (fi)
NZ (1) NZ228847A (fi)
SE (1) SE504625C2 (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104868A (en) * 1988-06-21 1992-04-14 Pfizer Inc. Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
IT1248011B (it) * 1991-06-07 1995-01-05 Mediolanum Farmaceutici Spa Procedimento per la preparazione dell'acido 9-fluoro-10- (4-metil-1-piperazinil)-7-oxo-2,3-diidro-7h-pirido (1,2,3-de) (1,4)benzotiadin-6-carbossilico cloridrato.
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
TW252107B (fi) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
IT1270834B (it) * 1993-10-27 1997-05-13 Archimica Spa Disolfuro chinolico
IT1270836B (it) * 1993-10-27 1997-05-13 Archimica Spa Procedimento per la preparazione di rufloxacina e suoi sali
USH1480H (en) * 1993-12-09 1995-09-05 The Procter & Gamble Company Methods of using dyphylline for the promotion of hair growth
KR100768034B1 (ko) 1999-03-17 2007-10-17 다이이찌 세이야꾸 가부시기가이샤 의약 조성물
KR20040105772A (ko) 2002-03-21 2004-12-16 바스프 악티엔게젤샤프트 살진균성 트리아졸로피리미딘, 이의 제조방법 및 유해진균 방제를 위한 이의 용도 및 상기 성분을 함유하는조성물
CN1332962C (zh) * 2005-07-12 2007-08-22 武汉人福药业有限责任公司 一种合成甲磺酸帕珠沙星中间体的方法
PL2383271T3 (pl) * 2006-03-13 2013-12-31 Kyorin Seiyaku Kk Aminochinolony jako inhibitory GSK-3
EP2203458B1 (en) * 2007-09-11 2011-11-02 Kyorin Pharmaceutical Co., Ltd. Cyanoaminoquinolones as gsk-3 inhibitors
CA2699152C (en) 2007-09-12 2015-11-24 Activx Biosciences, Inc. Spirocyclic aminoquinolones as gsk-3 inhibitors
JP5502889B2 (ja) * 2009-03-11 2014-05-28 杏林製薬株式会社 gsk−3阻害剤としての7−シクロアルキルアミノキノロン
CN101928290B (zh) * 2009-11-27 2011-11-09 浙江司太立制药股份有限公司 一种甲磺酸帕珠沙星的纯化方法
CN102295652A (zh) * 2011-06-27 2011-12-28 辽宁海神联盛制药有限公司 一种甲磺酸帕珠沙星合成工艺的改进方法
CN102850375A (zh) * 2012-03-06 2013-01-02 江西师范大学 一类多取代吡啶并[4, 3-d]噁嗪化合物及制备方法
CN103772412B (zh) * 2012-10-23 2016-03-16 浙江海森药业有限公司 一种帕珠沙星中间体的制备方法
CN105622632B (zh) * 2014-10-29 2018-06-29 浙江海森药业股份有限公司 一种喹诺酮类化合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883522A (en) * 1974-02-11 1975-05-13 Riker Laboratories Inc Substituted pyrido(1,2,3-de)-1,4-benzoxazines
DE3211984C2 (de) * 1981-05-21 1986-04-03 Dieter Dr. 7900 Ulm Benz Rotierende Zahnbürste
JPS591489A (ja) * 1982-06-29 1984-01-06 Dai Ichi Seiyaku Co Ltd ピリドベンゾオキサジン誘導体
DE3234529A1 (de) * 1982-09-17 1984-03-22 Bayer Ag, 5090 Leverkusen Substituierte benzoxazin-derivate
US4603199A (en) * 1982-10-25 1986-07-29 Riker Laboratories, Inc. Phenyl-substituted tricyclic antibacterial agent intermediates
US4607032A (en) * 1984-04-26 1986-08-19 Abbott Laboratories Quino-benoxazine antibacterial compounds
US4540694A (en) * 1984-04-26 1985-09-10 Abbott Laboratories 1-Pyridine substituted quino-benoxazines and antibacterial use
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
US4623650A (en) * 1984-12-06 1986-11-18 Pfizer Inc. Antibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
DE3522406A1 (de) * 1985-06-22 1987-01-02 Bayer Ag Verfahren zur herstellung von 1,8-verbrueckten 4-chinolon-3-carbonsaeuren
DE3522405A1 (de) * 1985-06-22 1987-01-02 Bayer Ag 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
DE3543513A1 (de) * 1985-12-10 1987-06-11 Bayer Ag Enantiomerenreine 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
US4777253A (en) * 1986-04-25 1988-10-11 Abbott Laboratories Process for preparation of racemate and optically active ofloxacin and related derivatives
IT1196429B (it) * 1986-07-01 1988-11-16 Mediolanum Farmaceutici Srl Processo per la preparazione di pirido benzotiazine ad attivita' antibatterica e loro sali con acidi solfonici
DE3623757A1 (de) * 1986-07-15 1988-01-21 Bayer Ag Neue 1,8-verbrueckte 4-chinoloncarbonsaeuren und diese enthaltende arzneimittel
DE3639465A1 (de) * 1986-11-18 1988-05-19 Hoechst Ag Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika
DE3641661A1 (de) * 1986-12-05 1988-06-30 Bayer Ag Verfahren zur herstellung von chinoloncarbonsaeureestern
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
JP2598921B2 (ja) * 1987-10-05 1997-04-09 富山化学工業株式会社 新規なキノリン誘導体およびその塩
DE3810080A1 (de) * 1988-03-25 1989-10-05 Bayer Ag Trisubstituierte 1,3,5-triazin-2,4,6-trione
DE3815481A1 (de) * 1988-05-06 1989-11-16 Sandoz Ag Sulfonsaeuregruppenfreie basische verbindung
US5039682A (en) * 1988-06-21 1991-08-13 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor

Also Published As

Publication number Publication date
US4990508A (en) 1991-02-05
CH680793A5 (fi) 1992-11-13
AU3266189A (en) 1989-10-26
FR2630441B1 (fr) 1994-10-14
CA1340493C (en) 1999-04-13
FI891910A (fi) 1989-10-24
SE8901464L (sv) 1989-10-24
FR2630441A1 (fr) 1989-10-27
DE3913245C2 (de) 1999-07-15
GB2217710B (en) 1991-12-04
DK192589A (da) 1989-10-24
GB8908096D0 (en) 1989-05-24
GB2217710A (en) 1989-11-01
JPH0228178A (ja) 1990-01-30
NL192832C (nl) 1998-03-04
FI891910A0 (fi) 1989-04-21
AT398422B (de) 1994-12-27
HU205759B (en) 1992-06-29
NL8901007A (nl) 1989-11-16
ES2016012A6 (es) 1990-10-01
SE8901464D0 (sv) 1989-04-21
IL89931A (en) 1993-06-10
HUT51621A (en) 1990-05-28
NZ228847A (en) 1990-04-26
DK192589D0 (da) 1989-04-20
HU211568A9 (en) 1995-12-28
FI91529C (fi) 1994-07-11
DE3913245A1 (de) 1989-11-02
KR910005833B1 (ko) 1991-08-05
AU601324B2 (en) 1990-09-06
KR900016222A (ko) 1990-11-12
DK175649B1 (da) 2005-01-03
NO891650L (no) 1989-10-24
ATA95989A (de) 1994-04-15
IT8947875A0 (it) 1989-04-21
NL192832B (nl) 1997-11-03
IT1231760B (it) 1991-12-21
IL89931A0 (en) 1989-12-15
NO171214B (no) 1992-11-02
SE504625C2 (sv) 1997-03-17
JPH0588714B2 (fi) 1993-12-24
NO171214C (no) 1993-02-10
BE1003252A4 (fr) 1992-02-11
NO891650D0 (no) 1989-04-21

Similar Documents

Publication Publication Date Title
FI91529B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyrido/1,2,3-de//1,4/bentsoksatsiinijohdannaisten valmistamiseksi
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI95704B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI913477A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten imidatsoli-fenyyli-imidatso/1,2-a/pyridiini- ja imidatsoli-fenyyli-imidatso/1,2-a/pyrimidiinijohdannaisten valmistamiseksi
FI95381C (fi) Menetelmä terapeuttisesti käyttökelpoisten, raseemisten tai optisesti aktiivisten pyrido/1,2-a/pyratsiinien valmistamiseksi
FI874459A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI892182A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI873350A (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI892948A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI903704A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI884660A0 (fi) Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
FI92202B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4-substituoitujen pyratsolo/3,4-d/pyrimidiinijohdannaisten valmistamiseksi
FI894520A0 (fi) Menetelmä terapeuttisesti aktiivisten 8-aminosubstituoitu-7,8-dihydro-6,6-dimetyyli-6H-pyrano/2,3-f/bentso-2,1,3-oksadiatsolien valmistamiseksi
FI892684A0 (fi) Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI900145A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI893434A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi
FI893250A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-diatsepiinijohdannaisten valmistamiseksi
FI893121A0 (fi) Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi
FI931891A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 7,8-dihydroksi-1H-imidatso- ja pyratsolo/3,4-f/kinoksaliinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: TOYAMA CHEMICAL CO., LTD.

MA Patent expired